Literature DB >> 22212557

Sgk1 sensitivity of Na(+)/H(+) exchanger activity and cardiac remodeling following pressure overload.

Jakob Voelkl1, Yun Lin, Ioana Alesutan, Mohamed Siyabeldin E Ahmed, Venkanna Pasham, Sobuj Mia, Shuchen Gu, Martina Feger, Ambrish Saxena, Bernhard Metzler, Dietmar Kuhl, Bernd J Pichler, Florian Lang.   

Abstract

Sustained increase of cardiac workload is known to trigger cardiac remodeling with eventual development of cardiac failure. Compelling evidence points to a critical role of enhanced cardiac Na(+)/H(+) exchanger (NHE1) activity in the underlying pathophysiology. The signaling triggering up-regulation of NHE1 remained, however, ill defined. The present study explored the involvement of the serum- and glucocorticoid-inducible kinase Sgk1 in cardiac remodeling due to transverse aortic constriction (TAC). To this end, experiments were performed in gene targeted mice lacking functional Sgk1 (sgk1 (-/-)) and their wild-type controls (sgk1 (+/+)). Transcript levels have been determined by RT-PCR, cytosolic pH (pH( i )) utilizing 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) fluorescence, Na(+)/H(+) exchanger activity by the Na(+)-dependent realkalinization after an ammonium pulse, ejection fraction (%) utilizing cardiac cine magnetic resonance imaging and cardiac glucose uptake by PET imaging. As a result, TAC increased the mRNA expression of Sgk1 in sgk1 (+/+) mice, paralleled by an increase in Nhe1 transcript levels as well as Na(+)/H(+) exchanger activity, all effects virtually abrogated in sgk1 (-/-) mice. In sgk1 (+/+) mice, TAC induced a decrease in Pgc1a mRNA expression, while Spp1 mRNA expression was increased, both effects diminished in the sgk1 (-/-) mice. TAC was followed by a significant increase of heart and lung weight in sgk1 (+/+) mice, an effect significantly blunted in sgk1 (-/-) mice. TAC increased the transcript levels of Anp and Bnp, effects again significantly blunted in sgk1 (-/-) mice. TAC increased transcript levels of Collagen I and III as well as Ctgf mRNA and CTGF protein abundance, effects significantly blunted in sgk1 (-/-) mice. TAC further decreased the ejection fraction in sgk1 (+/+) mice, an effect again attenuated in sgk1 (-/-) mice. Also, cardiac FDG-glucose uptake was increased to a larger extent in sgk1 (+/+) mice than in sgk1 (-/-) mice after TAC. These observations point to an important role for SGK1 in cardiac remodeling and development of heart failure following an excessive work load.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212557     DOI: 10.1007/s00395-011-0236-2

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  17 in total

1.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

2.  Na(+)/H (+) exchanger isoform 1 induced osteopontin expression in cardiomyocytes involves NFAT3/Gata4.

Authors:  Mohamed Mlih; Nabeel Abdulrahman; Alain-Pierre Gadeau; Iman A Mohamed; Maiy Jaballah; Fatima Mraiche
Journal:  Mol Cell Biochem       Date:  2015-03-11       Impact factor: 3.396

3.  Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.

Authors:  Jakob Voelkl; Ioana Alesutan; Christina B Leibrock; Leticia Quintanilla-Martinez; Volker Kuhn; Martina Feger; Sobuj Mia; Mohamed S E Ahmed; Kevin P Rosenblatt; Makoto Kuro-O; Florian Lang
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

Review 4.  Sodium chloride, SGK1, and Th17 activation.

Authors:  Katrina J Binger; Ralf A Linker; Dominik N Muller; Markus Kleinewietfeld
Journal:  Pflugers Arch       Date:  2014-12-04       Impact factor: 3.657

5.  Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin.

Authors:  Yue Xu; Kai Jiang; Feng Chen; Jie Qian; Dandan Wang; Yizhang Wu; Chunjiang Zhou; Yong Yu; Kun Chen; John Hwa; Bing Yang; Haiyun Wang; Yaozu Xiang
Journal:  Basic Res Cardiol       Date:  2022-09-28       Impact factor: 12.416

6.  Serum-glucocorticoid-regulated kinase 1 contributes to mechanical stretch-induced inflammatory responses in cardiac fibroblasts.

Authors:  Wenqiang Gan; Tiegang Li; Jingyuan Ren; Chenghe Li; Ziliang Liu; Min Yang
Journal:  Mol Cell Biochem       Date:  2017-12-14       Impact factor: 3.396

7.  High glucose-induced effects on Na+-K+-2Cl- cotransport and Na+/H+ exchange of blood-brain barrier endothelial cells: involvement of SGK1, PKCβII, and SPAK/OSR1.

Authors:  Nicholas R Klug; Olga V Chechneva; Benjamin Y Hung; Martha E O'Donnell
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-06       Impact factor: 4.249

8.  Na+/H+ exchanger isoform 1 induced cardiomyocyte hypertrophy involves activation of p90 ribosomal s6 kinase.

Authors:  Maiy Jaballah; Iman A Mohamed; Bayan Alemrayat; Fatima Al-Sulaiti; Mohamed Mlih; Fatima Mraiche
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

9.  Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization.

Authors:  Megan V Cannon; Herman H W Silljé; Jürgen W A Sijbesma; Inge Vreeswijk-Baudoin; Jolita Ciapaite; Bart van der Sluis; Jan van Deursen; Gustavo J J Silva; Leon J de Windt; Jan-Åke Gustafsson; Pim van der Harst; Wiek H van Gilst; Rudolf A de Boer
Journal:  EMBO Mol Med       Date:  2015-09       Impact factor: 12.137

10.  Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy.

Authors:  Iman A Mohamed; Alain-Pierre Gadeau; Larry Fliegel; Gary Lopaschuk; Mohamed Mlih; Nabeel Abdulrahman; Natasha Fillmore; Fatima Mraiche
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.